Literature DB >> 3013885

Activation of 45Ca2+ influx and 22Na+/H+ exchange by epidermal growth factor and vanadate in A431 cells is independent of phosphatidylinositol turnover and is inhibited by phorbol ester and diacylglycerol.

I G Macara.   

Abstract

Both epidermal growth factor (EGF) and vanadate can activate 45Ca2+ influx into A431 epidermal carcinoma cells, without a detectable lag period possibly via a voltage-independent calcium channel. 22Na+/H+ exchange and 45Ca2+ uptake are mutually independent. Neither EGF nor vanadate induce any significant change in the steady-state levels of [1,3-3H]glycerol-labeled diacylglycerol, myo-[2-3H]inositol-labeled inositol trisphosphate or in 32P-labeled polyphosphoinositides or phosphatidic acid over the first 10 min of treatment, suggesting that the EGF receptor is not directly coupled to phosphatidylinositol turnover and that the two ion fluxes are not induced via a kinase C-dependent pathway. An increase in turnover of polyphosphoinositides can be detected in EGF-stimulated cells by nonequilibrium labeling with [32P]phosphate, but the increase shows a lag of about 1 min under the conditions used to detect 45Ca2+ influx. Chelation of free Ca2+ decreases but does not abolish the EGF-stimulated turnover. Preincubation with tetradecanoylphorbol acetate or 1-oleoyl-2-acetylglycerol inhibits the increase in 45Ca2+ uptake by both EGF and vanadate. Tetradecanoylphorbol acetate alone does not alter the basal rate of influx when added together with 45Ca2+. Surprisingly, the activation by vanadate and its inhibition by phorbol 12-myristate 13-acetate are unaffected by down-regulation of the EGF receptors through prior incubation with growth factor. Therefore, in A431 cells the activation of Na+/H+ exchange and Ca2+ influx appear to be independent of phosphatidylinositol turnover, and the EGF receptor does not itself function as a Ca2+ channel. Vanadate apparently activates influx through a mechanism distinct from or distal to the EGF receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013885

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Variety of Ca(2+)-permeable channels in human carcinoma A431 cells.

Authors:  G N Mozhayeva; A P Naumov
Journal:  J Membr Biol       Date:  1991-11       Impact factor: 1.843

2.  Redistribution of subcellular calcium in rat liver on administration of vanadate.

Authors:  S Gullapalli; V Shivaswamy; T Ramasarma; C K Kurup
Journal:  Mol Cell Biochem       Date:  1989-10-31       Impact factor: 3.396

3.  Epidermal growth factor-urogastrone causes vasodilatation in the anesthetized dog.

Authors:  B S Gan; K L MacCannell; M D Hollenberg
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

4.  Adenylate cyclase 5 and KCa1.1 channel are required for EGFR up-regulation of PCNA in native contractile rat basilar artery smooth muscle.

Authors:  Alexander Ivanov; Volodymyr Gerzanich; Svetlana Ivanova; Ryan Denhaese; Orest Tsymbalyuk; J Marc Simard
Journal:  J Physiol       Date:  2005-11-10       Impact factor: 5.182

Review 5.  Second messengers derived from inositol lipids.

Authors:  K J Catt; L Hunyady; T Balla
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

6.  Evidence for glomerular actions of epidermal growth factor in the rat.

Authors:  R C Harris; R L Hoover; H R Jacobson; K F Badr
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

7.  Epidermal growth factor stimulates rat cardiac adenylate cyclase through a GTP-binding regulatory protein.

Authors:  B G Nair; H M Rashed; T B Patel
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

8.  Vanadate mimics effects of fungal cell wall in eliciting gene activation in plant cell cultures.

Authors:  M Steffens; F Ettl; D Kranz; H Kindl
Journal:  Planta       Date:  1989-02       Impact factor: 4.116

9.  In vivo insulin resistance in streptozotocin-diabetic rats--evidence for reversal following oral vanadate treatment.

Authors:  O Blondel; D Bailbe; B Portha
Journal:  Diabetologia       Date:  1989-03       Impact factor: 10.122

10.  Activation of multiple pH-regulatory pathways in granulocytes by a phosphotyrosine phosphatase antagonist.

Authors:  L Bianchini; A Nanda; S Wasan; S Grinstein
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.